Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis

Journal of Thrombosis and Thrombolysis

Volumn 33, Issue 4, 2012, Pages 416-421

  Rios, Danyelle R A ^a,b   Fernandes, Ana Paula ^a   Figueiredo, Roberta C ^a   Guimarães, Daniela A M ^a   Ferreira, Cláudia N ^a   Simões e Silva, Ana C ^a   Carvalho, Maria G ^a   Gomes, Karina B ^a   Dusse, Luci Maria Sant Ana ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO JOÃO DEL REI   (Brazil)

Author keywords

ABO blood group; ADAMTS13; FVIII; Hemodialysis; VWF

Indexed keywords

BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; BIOLOGICAL MARKER; F8 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RISK FACTOR; THROMBOSIS; ADOLESCENT; AGED; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ABO BLOOD-GROUP SYSTEM; ADAM PROTEINS; ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FACTOR VIII; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 84865110256     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0719-5     Document Type: Article

References (38)

1. Smits JHM, van der Linden J, Blankestijn PJ, Rabelink TJ (2000) Coagulation and haemodialysis access thrombosis. Nephrol Dial Transplant 15:1755-1760
2. Lee AHRM (2000) ABO blood group system: a review of molecular aspects. Immunohematology 16:1-7
3. Batissoco ACNM (2003) Aspectos moleculares do Sistema Sangui ́neo ABO. Revista Brasileira de Hematologia e Hemoterapia 25:47-58
4. Schleef M, Strobel E, Dick A, Frank J, Schramm W, Spannagl M (2005) Relationship between ABO and secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals. Br J Haematol 128: 100-107
5. Larsen TB, Johnsen SP, Gislum M, Moller CAI, Larsen H, Sorensen HT (2005) ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study. J Thromb Haemost 3:300-304
6. Morelli VM, De Visser MCH, Vos HL, Bertina RM, Rosendaal FR (2005) ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost 3: 183-185
7. Ohira T, Cushman M, Tsai MY et al (2007) ABO blood group, other risk factors and incidence of venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). J Thromb Haemost 5:1455-1461
8. Paiva SG, Sabina AP, Carvalhoa MG et al (2009) Polymorphisms in exons 6 and 7 of the ABO locus and their association with venous thrombosis in young Brazilian patients. Blood Coagul Fibrinolysis 20:122-128
9. Kamphuisen PW, Eikenboom JCJ, Bertina RM (2001) Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 21:731-738
10. Sousa NC, Anicchino-Bizzacchi JM, Locatelli MF, Castro V, Barjas-Castro ML (2007) The relationship between ABO groups and subgroups, factor VIII and von Willebrand factor. Haematologica 92:236-239
11. Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W (1985) Factor-VIII and factor-IX in a twin population -evidence for a major effect of ABO locus on factor-VIII level. Am J Hum Genet 37:89-101
12. Anstadt MP, Carwile JM, Guill CK et al (2002) Relapse of thrombotic thrombocytopenic purpura associated with decreased VWF cleaving activity. Am J Med Sci 323:281-284
13. Ruggeri ZM (1997) von Willebrand factor. J Clin Invest 99:559-564
14. Hoffman M, Monroe DM (2007) Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin N Am 21:1-11
15. Conlan MG, Folsom AR, Finch A et al (1993) Associations of factor-VIII and von-Willebrand-factor with age, race, sex, and risk-factors for atherosclerosis -the atherosclerosis risk in communities (ARIC) study. Thromb Haemost 70:380-385
16. Cushman M, Yanez D, Psaty BM et al (1996) Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly -the cardiovascular health study. Am J Epidemiol 143:665-676
17. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE (1997) Prospective study of hemostatic factors and incidence of coronary heart disease -the atherosclerosis risk in communities (ARIC) study. Circulation 96:1102-1108
18. Carvalho MG, Silva MBS (1988) Hematology: laboratory techniques and interpretation [in Portuguese]. UFMG Editors, Belo Horizont, pp 1-139
19. Jubelirer SJ (1985) Hemostatic abnormalities in renal-disease. Am J Kidney Dis 5:219-225
20. Feldman HI, Kobrin S, Wasserstein A (1996) Hemodialysis vascular access morbidity. J Am Soc Nephrol 7:523-535
21. Tirado I, Mateo J, Soria JM et al (2005) The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 93:468-474
22. Bowen DJ (2003) An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost 1:33-40
23. O'Donnell JS, McKinnon TAJ, Crawley JTB, Lane DA, Laffan MA (2005) Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13proteolysis. Blood 106:1988-1991
24. Franchini M, Capra F, Targher G, Montagnana M, Lippi G (2007) Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J 5:14
25. Alpoim PN, Gomes KB, Godoi LC et al (2011) ADAMTS13, FVIII, von Willebrand factor, ABO blood group assessment in preeclampsia. Clin Chim Acta 412:2162-2166
26. Uemura M, Fujimura Y, Ko S, Matsumoto M, Nakajima Y, Fukui H (2010) Pivotal role of ADAMTS13 function in liver diseases. Int J Hematol 91:20-29
27. Matsumoto M, Chisuwa H, Nakazawa Y et al (2000) Liver transplantation rescues a deficient state of von Willebrand factorcleaving protease activity in patients with liver cirrhosis due to congenital biliary atresia. Blood 96:2733
28. Zheng XL, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K (2001) Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 276:41059-41063
29. Levy GG, Nichols WC, Lian EC et al (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488-494
30. Soejima K, Mimura N, Hirashima M et al (2001) A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease? J Biochem 130:475-480
31. Suzuki M, Murata M, Matsubara Y et al (2004) Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets. Biochem Biophys Res Commun 313:212-216
32. Turner N, Nolasco L, Tao Z, Dong JF, Moake J (2006) Human endothelial cells synthesize and release ADAMTS-13. J Thromb Haemost 4:1396-1404
33. Manea M, Kristoffersson A, Schneppenheim R et al (2007) Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura. Br J Haematol 138:651-662
34. Rios MA, Carvalho MG, Fernandes AP, Gomes KB, Dusse LM, Simoes e Silva AC (2011) ADAMTS13 and von Willebrand factor assessment before and after kidney transplantation. Clin Chim Acta 412:2353-2354
35. Stepanian A, Cohen-Moatti M, Sanglier T et al (2011) von Willebrand Factor and ADAMTS13 a candidate couple for preeclampsia pathophysiology. Arterioscler Thromb Vasc Biol 31:1703-1709
36. Latruada A, Rossi E, Calzarossa C, Candolfi R, Mannucci PM (2003) Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microanglopathic syndrome. Haematologica 88:1029-1034
37. Taniguchi S, Hashiguchi T, Ono T et al (2010) Association between reduced ADAMTS13 and diabetic nephropathy. Thromb Res 125:E310-E316
38. Ono T, Mimuro J, Madoiwa S et al (2006) Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood 107:528-534